Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Plos One|September 23, 2022
Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemicAdya Rao, Louisa Moorhouse, Rufu Maswera, et al.
Journal of Global Health|January 19, 2023
Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The GambiaNora Schmit, Shevanthi Nayagam, Maud Lemoine, et al.
The Lancet. Infectious Diseases|September 18, 2016
Requirements for global elimination of hepatitis B: a modelling studyShevanthi Nayagam, Mark Thursz, Elisa Sicuri, et al.
The Lancet. Gastroenterology & Hepatology|May 7, 2023
Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling studyShevanthi Nayagam, Margaret J de Villiers, Yusuke Shimakawa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 5, 2020
Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in EnglandZameer Mohamed, Nick Scott, Deyaa Al-Kurdi, et al.
JHEP Reports : Innovation in Hepatology|July 22, 2024
Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: A systematic review and meta-analysisHugues Delamare, Julian Euma Ishii-Rousseau, Adya Rao, et al.
The International Journal on Drug Policy|October 8, 2021
Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, TanzaniaZameer Mohamed, Nick Scott, Shevanthi Nayagam, et al.
Value in Health Regional Issues|June 4, 2026
Health-related Quality of Life in Patients With Chronic Hepatitis B and Liver-Related Complications in The GambiaYazan Haddadin, Amelia Cook, Alpha Suso, et al.
The Lancet. Global Health|December 14, 2023
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysisLiem B Luong Nguyen, Maud Lemoine, Gibril Ndow, et al.
The Lancet. Global Health|July 23, 2016
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysisShevanthi Nayagam, Lesong Conteh, Elisa Sicuri, et al.
Pageof 5